Running Royalties. Licensee shall pay to TSRI running royalties on a Program by Program basis, and a Product by Product and country-by country basis, on Net Sales of Product in the Territory (“Royalties”) as set forth below:
Appears in 3 contracts
Samples: License Agreement (Neumora Therapeutics, Inc.), License Agreement (Neumora Therapeutics, Inc.), License Agreement (Neumora Therapeutics, Inc.)
Running Royalties. Licensee shall pay to TSRI running royalties on a Program by Program basis, and a Product by Licensed Product-by-Licensed Product and country-by by-country basis, on basis in the amount of (a) [***] of Net Sales of Product Licensed Products that are commercialized by the Licensee, its Affiliates or a Sublicensee. [***] Certain information in this document has been omitted and filed separately with the Territory (“Royalties”) as set forth below:Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Appears in 2 contracts
Samples: License Agreement (Corvus Pharmaceuticals, Inc.), License Agreement (Corvus Pharmaceuticals, Inc.)
Running Royalties. Licensee agrees to pay and shall pay to TSRI running royalties on a Program country by Program basis, country and a Product by Product and country-by country basis, on Net Sales of Product in basis at the Territory (“Royalties”) as applicable rates set forth below:
Appears in 1 contract
Running Royalties. Licensee shall pay to TSRI running royalties on a Program by Program basis, and a Product by Licensed Product-by-Licensed Product and country-by by-country basis, on basis in the amount of *** of Net Sales of Licensed Products in all countries in which the manufacture, use, sale, offer for sale or import of such Licensed Product would, in the Territory (“Royalties”) as set forth below:absence of the license under the Licensed Patent Rights granted by this Agreement, infringe one or more Valid Claims in that country.
Appears in 1 contract
